Diabetes Archives

Author reviews the pathophysiology of obesity including the role of incretin hormones and the mechanism of action, efficacy, and safety of GLP-1 receptor agonists as antiobesity medications.

News

Dulaglutide Improves Glycemic Control in Youth With Uncontrolled T2D

By

Diana Ernst, RPh

June 7, 2022

Dulaglutide is a glucagon-like peptide-1 receptor agonist.

Endocrinology

Obesity in Adolescence Linked to Type 1 Diabetes in Adulthood

By

Nikki Kean

June 6, 2022

Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.

Medicine

Dementia Risk in Patients With Atrial Fibrillation Tied to Diabetes, Stroke

By

Sheila Jacobs

May 20, 2022

Researchers sought to assess the risk factors for dementia in older adults with atrial fibrillation.

Endocrinology

Obesity-Associated Microvascular and Macrovascular Complications Among Patients With Diabetes

By

Jessica Nye, PhD

May 19, 2022

Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.

Medicine

Possible Causal Relationship Between COVID-19 and Gestational Diabetes Onset

By

Jessica Nye, PhD

May 17, 2022

Researchers assessed the prevalence of gestational diabetes among women with COVID-19 infection who were pregnant and the risk factors associated with severe disease.

Medicine

Maintenance of Intermittent Fasting for Weight Loss and Metabolic Health Improvements

By

Jessica Nye, PhD

May 13, 2022

A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.

Medicine

AHA Outlines Strategies to Improve Nutrition Security in the US

By

Kristin Della Volpe

May 11, 2022

While food insecurity is a leading public health issue, research shows that nutrition security may be a better target for disease prevention strategies.